A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression

How dedifferentiated stem-like tumor cells evade immunosurveillance remains poorly understood. We show that the lineage-plasticity regulator SOX9, which is upregulated in dedifferentiated tumor cells, limits the number of infiltrating T lymphocytes in premalignant lesions of mouse basal-like breast cancer. SOX9-mediated immunosuppression is required for the progression of in situ tumors to invasive carcinoma. SOX9 induces the expression of immune checkpoint B7x/B7-H4 through STAT3 activation and direct transcriptional regulation. B7x is upregulated in dedifferentiated tumor cells and protects them from immunosurveillance. B7x also protects mammary gland regeneration in immunocompetent mice. In advanced tumors, B7x targeting inhibits tumor growth and overcomes resistance to anti-PD-L1 immunotherapy. In human breast cancer, SOX9 and B7x expression are correlated and associated with reduced CD8+ T cell infiltration. This study, using mouse models, cell lines, and patient samples, identifies a dedifferentiation-associated immunosuppression mechanism and demonstrates the therapeutic potential of targeting the SOX9-B7x pathway in basal-like breast cancer.

Automated analgesic drugs delivery guided by vagal tone evaluation: interest of the Analgesia Nociception Index (ANI)

Analgesic drugs delivery optimization constitutes one of the main objectives of modern anesthesia. Indeed, their over or under determination constitutes a risk for anesthetized patient in terms of hemodynamic reactivity or post-operative hyperalgesia. Nowadays, new physiological indexes allow anesthesiologists to evaluate the balance between the analgesia level and the noxious stimulus importance. ANI is an index related to the autonomic nervous system activity based on heart rate variability analysis. Its ability for the analgesia / nociception balance evaluation has been established bringing evidences about its helpfulness for analgesic drug delivery. In this article, we describe a device for automatic analgesic drugs administration based on the ANI evolution during surgical procedures under general anesthesia. We hypothesized that such a device could improve the quality and safety of anesthesia by reducing adverse cardiovascular events and delivered analgesic drugs doses.